C
COGT icon

Covestor’s Cogent Biosciences COGT Stock Holding History

Covestor’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10K Buy
270
+252
+1,400% +$9.3K 0.01% 1386
2025
Q4 		$1K Hold
18
– – ﹤0.01% 2015
2025
Q3 		$0 Hold
18
– – ﹤0.01% 2341
2025
Q2 		$0 Buy
18
+7
+64% +$39 ﹤0.01% 2275
2025
Q1 		$0 Hold
11
– – ﹤0.01% 2287
2024
Q4 		$0 Buy
11
+1
+10% +$10 ﹤0.01% 2294
2024
Q3 		$0 Sell
10
-1
-9% -$10 ﹤0.01% 2282
2024
Q2 		$0 Hold
11
– – ﹤0.01% 2296
2024
Q1 		$0 Sell
11
-4
-27% -$25 ﹤0.01% 2297
2023
Q4 		$0 Buy
15
+8
+114% +$61 ﹤0.01% 2205
2023
Q3 		$0 Sell
7
-1
-13% -$12 ﹤0.01% 2177
2023
Q2 		$0 Hold
8
– – ﹤0.01% 2189
2023
Q1 		$0 Hold
8
– – ﹤0.01% 2084
2022
Q4 		$0 Buy
+8
New +$99 ﹤0.01% 2117

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Covestor's COGT Position: Q1 2026 in Review

Covestor increased its Cogent Biosciences (COGT) stake by 1,400% in Q1 2026, buying an estimated $9.3K and bringing the position to 270 shares worth $10K. The position accounts for 0.01% of the portfolio, ranked #1386.

Covestor first reported a position in COGT in Q4 2022 and has held it in 14 quarters since. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Covestor held 270 shares of Cogent Biosciences worth $10K as of Q1 2026.
  • Covestor bought 252 Cogent Biosciences shares in Q1 2026, an estimated $9.3K.
  • Cogent Biosciences made up 0.01% of Covestor's portfolio in Q1 2026, its #1386 holding.
  • Covestor first reported a position in Cogent Biosciences in Q4 2022 and has held it in 14 quarters since.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.